Home Carboxes 1219827-56-1
1219827-56-1,MFCD16653309
Catalog No.:AA01AQMZ

1219827-56-1 | TERT-BUTYL 4-(PROP-2-YN-1-YLOXY)PIPERIDINE-1-CARBOXYLATE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$125.00   $88.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01AQMZ
Chemical Name:
TERT-BUTYL 4-(PROP-2-YN-1-YLOXY)PIPERIDINE-1-CARBOXYLATE
CAS Number:
1219827-56-1
Molecular Formula:
C13H21NO3
Molecular Weight:
239.3107
MDL Number:
MFCD16653309
SMILES:
C#CCOC1CCN(CC1)C(=O)OC(C)(C)C
Properties

Downstream Synthesis Route

[1]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-US2019/192668,2019,A1Locationinpatent:Paragraph3869;3870

[2]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/113233,2020,A1Locationinpatent:Paragraph00962;001647-001648

[3]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/264490,2020,A1Locationinpatent:Paragraph00794;00827-00828

[4]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/158634,2021,A1Locationinpatent:Paragraph00558

[5]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/247897,2021,A1Locationinpatent:Paragraph00426;00496-00497

[6]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/188948,2021,A1Locationinpatent:Paragraph00890-00892;001252-001253

[7]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/188948,2021,A1Locationinpatent:Paragraph00890-00892;001252-001253

[8]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/247899,2021,A1Locationinpatent:Paragraph0009

[9]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/247897,2021,A1Locationinpatent:Paragraph00426;00496-00497

[10]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2022/125790,2022,A1Locationinpatent:Paragraph00823;00824

[11]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2022/125790,2022,A1Locationinpatent:Paragraph00823;00824

[12]CurrentPatentAssignee:WUHANRENFUINNOVATIVEDRUGRDCENTER;HUMANWELLHEALTHCARE(GROUP)CO.,LTD.-CN113943276,2022,ALocationinpatent:Paragraph0301-0306

[13]CurrentPatentAssignee:WUHANRENFUINNOVATIVEDRUGRDCENTER;HUMANWELLHEALTHCARE(GROUP)CO.,LTD.-CN113943276,2022,ALocationinpatent:Paragraph0301-0306

[14]CurrentPatentAssignee:AMGENINC-US2014/249104,2014,A1Locationinpatent:Page/Pagecolumn

[15]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/247899,2021,A1Locationinpatent:Paragraph0009

[1]CurrentPatentAssignee:AMGENINC-US2014/249104,2014,A1Locationinpatent:Page/Pagecolumn

[2]CurrentPatentAssignee:WUHANRENFUINNOVATIVEDRUGRDCENTER;HUMANWELLHEALTHCARE(GROUP)CO.,LTD.-CN113943276,2022,ALocationinpatent:Paragraph0301;0304;0307;0308

[3]CurrentPatentAssignee:WUHANRENFUINNOVATIVEDRUGRDCENTER;HUMANWELLHEALTHCARE(GROUP)CO.,LTD.-CN113943276,2022,ALocationinpatent:Paragraph0301-0304;0307-0308

26166-92-7    1219827-56-1   
C26H29N3O7 

[1]CurrentPatentAssignee:ARVINAS-WO2018/140809,2018,A1Locationinpatent:Paragraph00423

1219827-56-1   
3-(5-bromo-3-methyl-2-oxo-2,3-dihydro-1H-benzodimidazol-1-yl)piperidine-2,6-dione 
 
tert-butyl4-3-1-(2,6-dioxo-3-piperidyl)-3-methyl-2-oxobenzimidazol-5-ylprop-2-ynoxypiperidine-1-carboxylate 

[1]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-US2019/192668,2019,A1Locationinpatent:Paragraph4367;4368

[2]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/113233,2020,A1Locationinpatent:Paragraph002284-002286;004969-004970

[3]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/264490,2020,A1Locationinpatent:Paragraph00935-00937

1219827-56-1   
3-(4-bromo-3-methyl-2-oxo-2,3-dihydro-1H-benzodimidazol-1-yl)piperidine-2,6-dione 
 
tert-butyl4-3-1-(2,6-dioxo-3-piperidyl)-3-methyl-2-oxo-benzimidazol-4-ylprop-2-ynoxypiperidine-1-carboxylate 

[1]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-US2019/192668,2019,A1Locationinpatent:Sheet3871;3872

[2]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/113233,2020,A1Locationinpatent:Paragraph001649-001651

[3]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/264490,2020,A1Locationinpatent:Paragraph00829-00831

[4]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/158634,2021,A1Locationinpatent:Paragraph00559-00560

[5]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/247897,2021,A1Locationinpatent:Paragraph00426;00498-00500

[6]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/188948,2021,A1Locationinpatent:Paragraph00890;00893-00894;001254;001255-001256

[7]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/188948,2021,A1Locationinpatent:Paragraph00890;00893-00894;001254;001255-001256

[8]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/247899,2021,A1Locationinpatent:Paragraph0010

[9]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/247899,2021,A1Locationinpatent:Paragraph0010

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1219827-56-1
Building Blocks
More >
Tags:1219827-56-1 Molecular Formula|1219827-56-1 MDL|1219827-56-1 SMILES|1219827-56-1 TERT-BUTYL 4-(PROP-2-YN-1-YLOXY)PIPERIDINE-1-CARBOXYLATE